MAZE 8-K 2026-10-16

Maze Therapeutics, Inc. (MAZE) 8-K dated 2026-10-16 — accession 0001193125-26-424067. This URL is the filing, not the MAZE hub.

Maze Therapeutics, Inc. (MAZE) is a biotechnology company listed on US.

Maze Therapeutics, Inc. filed a 8-K on 2026-10-16. Accession 0001193125-26-424067.

Cached items: 1.01, 3.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported MAZE revenue for 2026-03-31 was $20.0M. Net income was -$24.2M. MAZE currently screens at market cap $525.3M.

Not investment advice. The MAZE SEC hub lists recent forms. The stock page is the research view.